Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

The number of people seeking medical care for three key illnesses — COVID-19, flu and respiratory syncytial virus, or RSV — ...

CDC wastewater also shows the XFG variant — nicknamed stratus — is most common in the U.S. Stratus can cause a “razor blade” ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Day Fiancé stars David Toborowsky and his wife Annie Suwan were worried about their baby Girl, Minthira. In July, David and Annie asked for prayers for their infant, and recently, David seemed to do ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Key Points GAAP revenue jumped 413% year over year to $11.8 million in Q2 2025, but fell far short of analyst estimates, with GAAP revenue of $11.8 million missing the consensus of $23.2 million by 49 ...

PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-yearInvivyd’s target of near-term profitability (1H 2025) was not met but remains ...

Suntory Beverage & Food GB&I COO Elise Seibold on how the Ribena and Lucozade supplier plans to bounce back from an ...

Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be ...

Heat is helpful for certain pathogens, like bacteria and fungi, that thrive in warm, humid conditions. However, during the ...